Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Recro Pharma Inc. (REPH)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Engine Capital

Arnaud Ajdler

473,484 $3,366 +22% 3.16%
2.
Broadfin Capital

Kevin Kotler

2,048,025 $14,561 2.14%
3.
Newtyn Management

Noah Levy And Eugene Dozortsev

1,329,611 $9,454 +50% 1.61%
4.
Lyon Street Capital

Brian C. Freckmann

111,618 $794 -78% 0.49%
5.
Opus Point Partners Management

Michael S. Weiss And Lindsay A. Rosenwald

11,353 $81 -11% 0.19%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.57 3,000 Director 7,000 2016-12-16 Filing
$6.53 4,000 Director 4,000 2016-12-15 Filing
$6.71 800 Director 800 2016-12-16 Filing
$6.55 1,500 Director 1,500 2016-12-15 Filing
$6.00 650,000 Large Shareholder 3,100,086 2016-12-13 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.51 25,000 Large Shareholder 2,048,025 2018-05-24 Filing
$5.65 50,000 Large Shareholder 2,073,025 2018-05-24 Filing
$6.00 45,700 Large Shareholder 2,123,025 2018-05-24 Filing
$5.99 38,000 Large Shareholder 2,168,725 2018-05-24 Filing
$5.84 29,300 Large Shareholder 2,206,725 2018-05-24 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 252,874 $1,798 0.21%
2. 46,616 $331 0.18%
3. 246,100 $1,750 0.03%
4. 35,490 $252 0.02%
5. 106,552 $751 0.01%
News See All